You are here

Glaxo presses on to find the next critical antibiotic

Despite the rise of superbugs, big pharma has largely exited antibiotic research because of low payoff

BT_20160922_KVANTIB22DY9L_2504673.jpg
Penicillin changed the world; infections that previously killed people were now treatable, paving the way for safer operations from organ transplants to hip replacements.

London

IN A cramped lab in rural Penn-sylvania, surrounded by technicians in obligatory white lab coats and fume hoods leaking an occasional acrid smell, Neil Pearson holds up a plastic model of a chemical compound that resembles a spidery piece of Lego.

Mr Pearson, a 54-year-old

sentifi.com

Market voices on:

Powered by GET.comGetCom